DORUK ERKAN

NEW YORK, NY NPI 1962465484

General Payments — all program years on this page

$85,621.18

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 82
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $20,242.38 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $633.943
2019 $9,378.0018
2020 $8,413.007
2021 $10,300.008
2022 $15,325.0012
2023 $21,328.8613
2024 $20,242.3821

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1115878198 GlaxoSmithKline, LLC. $88.28 07/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115911491 GlaxoSmithKline, LLC. $3,900.00 08/21/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1115986006 GlaxoSmithKline, LLC. $975.00 06/10/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1116180024 GlaxoSmithKline, LLC. $29.70 07/31/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1116186134 GlaxoSmithKline, LLC. $975.00 07/19/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1116225734 GlaxoSmithKline, LLC. $650.00 02/26/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1116237689 GlaxoSmithKline, LLC. $975.00 12/23/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1116305803 GlaxoSmithKline, LLC. $325.00 05/29/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1116486383 GlaxoSmithKline, LLC. $1,300.00 09/30/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1116487225 GlaxoSmithKline, LLC. $325.00 09/09/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1116651229 GlaxoSmithKline, LLC. $1,300.00 07/24/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1116734426 GlaxoSmithKline, LLC. $325.00 12/23/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1118836499 Otsuka Pharmaceutical Development & Commercialization, Inc. $3,465.00 04/05/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1131588027 PFIZER INC. $33.75 06/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132012930 PFIZER INC. $92.35 07/15/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1132012932 PFIZER INC. $2,800.00 09/30/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1133003336 Chugai Pharmaceutical Co., Ltd. $287.50 01/01/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1133003340 Chugai Pharmaceutical Co., Ltd. $47.90 04/01/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1133003344 Chugai Pharmaceutical Co., Ltd. $47.90 07/01/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1133003348 Chugai Pharmaceutical Co., Ltd. $575.00 11/13/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1133003352 F. Hoffmann-La Roche AG $1,725.00 10/01/2024 Consulting Fee Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.